Exploring Using Qsar And Pbpk Modeling To Improve Bioavailability During Lead Optimization
Let's dive into the details surrounding Using Qsar And Pbpk Modeling To Improve Bioavailability During Lead Optimization.
- Model-Informed Compound Development Track:
- In
- Watch this webinar to learn how physiologically based pharmacokinetic (
- Experience
- Marjory Moreau, PhD, Associate Director of Computational Toxicology, provides an overview of how to best
In-Depth Information on Using Qsar And Pbpk Modeling To Improve Bioavailability During Lead Optimization
In By: Eleftheria Tsakalozou, PhD (U.S. FDA) Wednesday 8th December 2021 (11am EST, 4pm GMT, 5pm CET) Establishing ... It is widely recognized that food can affect the absorption of orally administered drugs. Fang Wu from the Office of Generic Drugs discusses
The next generation of
That wraps up our extensive overview of Using Qsar And Pbpk Modeling To Improve Bioavailability During Lead Optimization.
